CIK 0001579428
- Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454241907
- Phone
- +1 212-332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-15 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −15,254 | $117.37 | $1.8M | 7,229 |
| 2025-09-12 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −27,907 | $118.96 | $3.3M | 7,229 |
| 2025-09-05 | Saad Mark E Director | Sale 10b5-1 | −9,127 | $125.07 | $1.1M | 10,002 |
| 2025-09-02 | JEFFS ROGER Director | Sale 10b5-1 | −13,464 | $123.68 | $1.7M | 57,510 |
| 2025-08-29 | JEFFS ROGER Director | Sale 10b5-1 | −20,000 | $121.27 | $2.4M | 70,974 |
| 2025-08-28 | JEFFS ROGER Director | Sale 10b5-1 | −20,000 | $121.60 | $2.4M | 90,974 |
| 2025-08-27 | JEFFS ROGER Director | Sale 10b5-1 | −20,000 | $122.30 | $2.4M | 110,974 |
| 2025-08-26 | JEFFS ROGER Director | Sale 10b5-1 | −20,000 | $120.03 | $2.4M | 130,974 |
| 2025-08-22 | JEFFS ROGER Director | Sale 10b5-1 | −16,694 | $120.08 | $2.0M | 150,974 |
| 2025-06-23 | Murdock Hunter R. General Counsel | Sale 10b5-1 | −6,014 | $100.12 | $602K | 0 |
| 2025-06-20 | Murdock Hunter R. General Counsel | Sale 10b5-1 | −7,500 | $102.47 | $769K | 0 |
| 2025-06-18 | Murdock Hunter R. General Counsel | Sale 10b5-1 | −7,500 | $100.90 | $757K | 0 |
| 2025-06-17 | Murdock Hunter R. General Counsel | Sale 10b5-1 | −7,500 | $100.26 | $752K | 0 |
| 2025-06-16 | Murdock Hunter R. General Counsel | Sale 10b5-1 | −7,500 | $102.42 | $768K | 0 |
| 2025-06-09 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −25,000 | $110.44 | $2.8M | 5,783 |
| 2025-05-28 | Coleman Mark Director | Sale 10b5-1 | −3,750 | $103.43 | $388K | 46,637 |
| 2025-05-28 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −20,000 | $103.45 | $2.1M | 5,783 |
| 2025-05-27 | Coleman Mark Director | Sale 10b5-1 | −3,750 | $105.47 | $396K | 50,387 |
| 2025-05-27 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −20,673 | $104.66 | $2.2M | 5,783 |
| 2025-05-20 | Coleman Mark Director | Sale | −3,000 | $107.49 | $322K | 54,137 |
Page 3 of 4 · 73 trades